Cases 11 - 20 of 77
CMP Development, LLC v. Hetero USA Inc. et al
as 1:2023cv00747
Plaintiff:
CMP Development, LLC
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit - III and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
AbbVie Inc. v. Hetero Labs Limited et al
as 1:2023cv00448
Plaintiff:
AbbVie Inc.
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. et al v. Alkem Laboratories Limited et al
as 1:2022cv01423
Plaintiff:
AbbVie Inc., AbbVie Ltd. and Neurocrine Biosciences, Inc.
Defendant:
Alkem Laboratories Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Hetero USA Inc. et al
as 1:2023cv00048
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation and others
Defendant:
Hetero USA Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB et al v. Annora Pharma Private Limited et al
as 1:2022cv01209
Plaintiff:
AstraZeneca AB and AstraZeneca Pharmaceuticals LP
Defendant:
Annora Pharma Private Limited, Hetero Labs Limited and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al
as 1:2022cv00696
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant:
Hetero Labs Limited Unit V and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme Corp. et al v. Hetero Labs Limited et al
as 1:2022cv00378
Plaintiff:
Merck Sharp & Dohme Corp., MSD International Business GmbH, MSD International GmbH and others
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Hetero USA Inc. et al
as 1:2021cv01760
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Hetero USA Inc., Hetero Labs Limited and Hetero Labs Limited Unit III
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
